Abcb5(+) stem cells for treating ocular disease
US-2015374756-A1 · Dec 31, 2015 · US
US2020010800A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2020010800-A1 |
| Application number | US-201816482160-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jan 31, 2018 |
| Priority date | Jan 31, 2017 |
| Publication date | Jan 9, 2020 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a method for controlling differentiation of pluripotent stem cells, which method comprises selecting a laminin or a fragment thereof based on binding affinity for the pluripotent stem cells and inducing differentiation of the pluripotent stem cells in the presence of the laminin or a fragment thereof. Here, the binding affinity for cells can be assessed by time-course observation of the survival rate and motility of the cells. According to the present invention, a cell population containing any desired proportion of differentiated cells can be produced from pluripotent stem cells in a simple manner. The cell population obtained by this production method is very useful for cell therapy-based treatment strategies for diseases.
Opening claim text (preview).
1 . A method for controlling differentiation of pluripotent stem cells toward corneal epithelial cells, the method comprising: inducing differentiation of the pluripotent stem cells in the presence of laminin 332 or a laminin 332E8 fragment, which directs differentiation toward corneal epithelial cells. 2 - 12 . (canceled) 13 . A method for controlling differentiation of pluripotent stem cells toward neural crest cells, the method comprising inducing differentiation of the pluripotent stem cells in the presence of laminin 211 or a laminin 211E8 fragment, which directs differentiation toward neural crest cells. 14 . A method for controlling differentiation of pluripotent stem cells toward retinal cells or neural crest cells, the method comprising inducing differentiation of the pluripotent stem cells in the presence of laminin 411 or a laminin 411E8 fragment, which directs differentiation toward retinal cells or neural crest cells. 15 . A method for producing an eye-related cell population, comprising culturing differentiated cells derived from pluripotent stem cells by the method according to claim 1 . 16 . The method according to claim 15 , wherein the cell population to be produced is a corneal epithelial cell population. 17 . A method for fabricating a corneal epithelial cell sheet for transplantation using a corneal epithelial cell population produced by the method according to claim 16 . 18 . A method for producing an eye-related cell population, comprising culturing differentiated cells derived from pluripotent stem cells by the method according to claim 13 . 19 . A method for producing an eye-related cell population, comprising culturing differentiated cells derived from pluripotent stem cells by the method according to claim 14 .
Proteins not provided for elsewhere · CPC title
Eye cells, e.g. cornea, iris pigmented cells (photoreceptors C12N5/062) · CPC title
Fibronectin; Laminin · CPC title
from artificially induced pluripotent stem cells · CPC title
Growth factors; Growth regulators · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.